πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

11,276 results for β€œTe” Clear

  1. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma (MM)

    phase 3 small molecule active

    1 trial

  2. Lipid-lowing Tea

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemia

    phase 3 small molecule active

    1 trial

  3. Liposomal Amphotericin B (LAmB)

    Duke University

    Talaromycosis

    phase 3 small molecule active

    1 trial

  4. Liposomal Ciclosporin A, Liposomal Ciclosporin A

    Zambon SpA

    Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation

    phase 3 small molecule active

    1 trial

  5. Liposomal bupivacaine

    Pacira Ireland Limited

    Surgery

    phase 3 small molecule completed

    1 trial

  6. Liraglutide placebo, Saxenda 6 mg/mL solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    phase 3 small molecule active

    1 trial

  7. Lisdexamfetamine Dimesylate (LDX)

    Takeda

    ADHD

    phase 3 small molecule completed

    3 trials

  8. Lisdexamfetamine dimesylate

    Takeda

    Binge Eating Disorder

    phase 3 small molecule completed

    2 trials

  9. Live Attenuated Respiratory Syncytial Virus (RSV) βˆ†NS2/βˆ†1313/I1314L vaccine, Matched

    Sanofi-aventis Healthcare Pty Ltd

    Virus diseases

    phase 3 small molecule active

    1 trial

  10. Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immunoglobulin Light-chain Amyloidosis

    phase 3 small molecule active

    1 trial

  11. Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation Proctitis

    phase 3 small molecule active

    1 trial

  12. Live attenuated Japanese encephalitis chimeric virus vaccine

    Sanofi Pasteur

    Japanese Encephalitis

    phase 3 mab completed

    1 trial

  13. Live attenuated SA 14-14-2 vaccine

    Repatha

    Encephalitis, Japanese B

    phase 3 mab completed

    1 trial

  14. Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab active

    1 trial

  15. Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus

    Sanofi Pasteur

    Dengue Fever

    phase 3 mab completed

    1 trial

  16. Live-Attenuated influenza Vaccine(LAIV)

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    phase 3 mab completed

    1 trial

  17. Livmoniplimab, ATEZOLIZUMAB, TREMELIMUMAB, BEVACIZUMAB, Budigalimab, IMFINZI 50 mg/mL concentrate for solution for infusion.

    AbbVie Deutschland GmbH & Co. KG

    Metastatic Hepatocellular Carcinoma (HCC)

    phase 3 small molecule active

    1 trial

  18. Lixisenatide (AVE0010)

    Sanofi Pasteur

    Acute Coronary Syndrome

    phase 3 small molecule completed

    1 trial

  19. Lixivaptan

    Centessa Pharmaceuticals plc

    Autosomal Dominant Polycystic Kidney

    phase 3 small molecule terminated

    1 trial

  20. Lixivaptan

    Centessa Pharmaceuticals plc

    Polycystic Kidney Disease, Adult

    phase 3 small molecule terminated

    2 trials

  21. Locally sourced sterile 0.9% (w/v) sodium chloride, JEMPERLI 500 mg concentrate for solution for infusion

    GlaxoSmithKline

    Neoplasms, Head and Neck

    phase 3 small molecule active

    1 trial

  22. Locametz 25 micrograms kit for radiopharmaceutical preparation, ABIRATERONE , LEUPRORELIN , HISTRELIN , ENZALUTAMIDE , TRIPTORELIN , NILUTAMIDE , Pluvicto 1 000 MBq/mL solution for injection/infusion, GOSERELIN , DEGARELIX , BICALUTAMIDE , BUSERELIN , -, RELUGOLIX , APALUTAMIDE , DAROLUTAMIDE , FLUTAMIDE

    Novartis Pharmaceuticals

    PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)

    phase 3 small molecule active

    1 trial

  23. Locametz 25 micrograms kit for radiopharmaceutical preparation, PIFLUFOLASTAT (18F), PIFLUFOLASTAT (18F), Pluvicto 1 000 MBq/mL solution for injection/infusion

    Novartis Pharmaceuticals

    Oligometastatic prostate cancer (OMPC)

    phase 3 small molecule active

    1 trial

  24. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources